Lee, Danner & Bass’s Idexx Laboratories IDXX Stock Holding History

Lee, Danner & Bass’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,176	Closed	-$486K	–	453
2024 Q4	$486K	Buy	+1,176	New	+$516K	0.04%	173

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Lee, Danner & Bass's IDXX Position: Q1 2025 in Review

Lee, Danner & Bass sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 1,176 shares — an estimated $486K sold.

Lee, Danner & Bass first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $486K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Lee, Danner & Bass reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 1,176 Idexx Laboratories shares in Q1 2025, an estimated $486K.
Lee, Danner & Bass first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's Idexx Laboratories position peaked at $486K in Q4 2024.
1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.